Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 8 Mar 2006 |
| Genmab, Clarification of Stock Exchange Notice No. 10 of March 2, 2006 | 3 Mar 2006 |
| Genmab, Capital Increase In Genmab As A Result Of Employee Warrant Exercise | 2 Mar 2006 |
| Genmab, Grant Of Warrants In Genmab A/S | 2 Mar 2006 |
| Genmab, notification from major shareholder (section 29) from Serono B.V. | 28 Feb 2006 |